Comment from 60 Degrees Pharmaceuticals Inc.

Summary: 60 Degrees Pharmaceuticals, Inc. supports the Commissioner’s National Priority Voucher (CNPV) Pilot Program but recommends making non-designated vouchers transferable and allowing sponsors to elect their voucher type. The company argues that transferability is essential for small, single-asset developers to secure the capital needed for clinical development and commercialization of treatments for underserved diseases like babesiosis.